<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02923128</url>
  </required_header>
  <id_info>
    <org_study_id>2015-01-13</org_study_id>
    <nct_id>NCT02923128</nct_id>
  </id_info>
  <brief_title>Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction</brief_title>
  <official_title>Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhejiang Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhejiang Cancer Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether postoperative analgesia pump continuous
      infusion of dexmedetomidine are effective in the prevention of Postoperative delirium and
      Postoperative cognitive dysfunction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. collection of cases: This trail is approved by Hospital Ethics Committee, and patients
           who participated in the study signed the informed consent. The subject will select 150
           elder patients (age ≥65 years) routine tumor surgery, American Society of
           Anesthesiologists classification-Ⅲ. Preoperative liver and kidney function, blood
           electrolytes were in the normal range.

        2. Case group: Selected cases divided into the right dexmedetomidine group and control
           group by computer randomly, 75 patients in each group. Dexmedetomidine group (A group)
           analgesia pump formula is: fentanyl 100ug + dexmedetomidine 150 ug, with 0.9% saline
           diluted to 150ml. Control group (group C) postoperative analgesia formula is: fentanyl
           150ug, with 0.9% saline diluted to 150ml. Two group with the same anesthesia program.
           Venous blood serum is taken before surgery, at the before end of surgery and when
           postoperative analgesia medication runs out (postoperative day 4) to test apolipoprotein
           E, Amyloid-β1-42, Amyloid-β1-40, N-terminal pro B-type natriuretic peptide.

        3. Post operative delirium and postoperative cognitive dysfunction diagnosis: Patients
           completed neuropsychological tests at entry to the study-generally the day before
           surgery-and at discharge from hospital or 1 week. The investigators assessed delirium by
           the Confusion Assessment Method for the intense care unit. The neuropsychological tests
           include Wechsler Adult Intelligence Scale-Revised by China Visual Reproduction、Wechsler
           Adult Intelligence Scale-Revised by China Digit Span、Digit-Symbol Substitution Test、The
           Stroop Color-Word Test、Trail Making Test A and Trail Making Test B. Patients had
           cognitive dysfunction when two Z scores in individual tests or the combined Z score were
           1.96 or more.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of postoperative cognitive dysfunction</measure>
    <time_frame>7 days after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative delirium</measure>
    <time_frame>3 days after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Postoperative Cognitive Dysfunction</condition>
  <condition>Postoperative Delirium</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine+routine PCIA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexmedetomidine 150ug is diluted to 150ml with 0.9% saline,continuous micro-pump infusion for 72 hours with 2ml/h speed.Routine patient controlled intravenous analgesia(PCIA) formula is sufentanyl(0.06ug.kg-1.h-1),diluted to 150ml with 0.9% saline,continuous micro-pump infusion for 72 hours with 2ml/h speed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine PCIA</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Routine patient controlled intravenous analgesia(PCIA) formula is sufentanyl(0.06ug.kg-1.h-1),diluted to 150ml with 0.9% saline,continuous micro-pump infusion for 72 hours with 2ml/h speed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine 150ug is diluted to 150ml with 0.9% saline,continuous micro-pump infusion for 72 hours with 2ml/h speed.</description>
    <arm_group_label>Dexmedetomidine+routine PCIA</arm_group_label>
    <other_name>Dexmedetomidine Hydrochloride Injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sufentanyl</intervention_name>
    <description>Sufentanyl(0.06ug.kg-1.h-1) is diluted to 150ml with 0.9% saline,continuous micro-pump infusion for 72 hours with 2ml/h speed.</description>
    <arm_group_label>Dexmedetomidine+routine PCIA</arm_group_label>
    <arm_group_label>Routine PCIA</arm_group_label>
    <other_name>Sufentanil Citrate Injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Saline is used to dilute other drugs</description>
    <arm_group_label>Dexmedetomidine+routine PCIA</arm_group_label>
    <arm_group_label>Routine PCIA</arm_group_label>
    <other_name>normal saline,physiological saline,NS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients' age ≥65 years

          -  Underwent elective non-cardiac surgery under general anesthesia

        Exclusion Criteria:

          -  Patients with severe bradycardia (heart rate&lt;55bpm)

          -  Severe arrhythmia or cardiac dysfunction (ejection fraction&lt;35%)

          -  Mini-Mental Scale Test (MMSE) Exclusion criteria: illiteracy &lt;18, primary school &lt;21,
             junior school and above &lt;25

          -  Preoperative clear systems and spiritual history of neurological disease or long-term
             use of sedatives or antidepressants

          -  History of alcohol abuse or a history of drug dependence

          -  Have brain surgery or trauma

          -  Severe vision or hearing impairment

          -  Cannot with the completion of tests of cognitive function

          -  Refused to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kangjie Xie, MD</last_name>
    <phone>008613516721870</phone>
    <email>xkj1243@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhejiang Cancer Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2016</study_first_submitted>
  <study_first_submitted_qc>October 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2016</study_first_posted>
  <last_update_submitted>October 8, 2016</last_update_submitted>
  <last_update_submitted_qc>October 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

